Originally published October 26 2005
Johns Hopkins researchers discover a new way to detect colon cancer
by Mike Adams, the Health Ranger, NaturalNews Editor
A non-invasive blood test for colon cancer has been developed by Bert Vogelstein and colleagues at Johns Hopkins University by altering a technique previously used to measure mutant DNA molecules.
While many cancers, including those of the colon, are curable if found early, the lack of sensitive, non-invasive screening tools for early stage cancers has limited progress in that area.
To develop a non-invasive blood test for colon cancer-associated genes, Bert Vogelstein and colleagues at Johns Hopkins University modified a technique they previously developed to measure minute quantities of mutant DNA molecules in blood plasma.
Using that technique, the researchers found elevated levels of mutated adenomatous polyposis coli gene in the plasma of patients with advanced-stage colorectal cancers.
Mutant genes also were detected in more than 60 percent of patients with early-stage cancers.
Scientists say the results may provide a foundation for a colon cancer screening tool for pre-symptomatic, at-risk populations and might also be adapted for several other cancer types for which there are no pre-symptomatic screening tests available.
The research appears in the online early edition of the Proceedings of the National Academy of Sciences.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml